More importantly, tissue microarray analysis of 756 breast cancer tumors demonstrated that PrPC was associated with ER-negative breast cancer subsets, and compared with ER-negative/PrPC-positive cells, ER-negative/PrPC-negative cells are more sensitive to adjuvant chemotherapy [70]. Here, PRNP is linked to breast carcinoma.